| 产品编号 | CFN60006 | |
| CAS编号 | 1232410-49-9 | |
| 分子式 = 分子量 | C18H16N4O3S = 368.4 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| VE-821 | CFN60006 | 1232410-49-9 | 1mg | QQ客服:215959384 |
| VE-821 | CFN60006 | 1232410-49-9 | 5mg | QQ客服:215959384 |
| VE-821 | CFN60006 | 1232410-49-9 | 10mg | QQ客服:215959384 |
| VE-821 | CFN60006 | 1232410-49-9 | 20mg | QQ客服:215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | VE-821 is a potent and selective ATP competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM in cell-free assays, shows inhibition of H2AX phosphorylation, minimal activity against PIKKs ATM, DNA-PK, mTOR and PI3Kγ. |
| Targets: | ATP | H2AX | mTOR | PI3K | DNA-PK | PIKKs |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.7144 mL | 13.5722 mL | 27.1444 mL | 54.2888 mL | 67.861 mL |
| 5 mM | 0.5429 mL | 2.7144 mL | 5.4289 mL | 10.8578 mL | 13.5722 mL |
| 10 mM | 0.2714 mL | 1.3572 mL | 2.7144 mL | 5.4289 mL | 6.7861 mL |
| 50 mM | 0.0543 mL | 0.2714 mL | 0.5429 mL | 1.0858 mL | 1.3572 mL |
| 100 mM | 0.0271 mL | 0.1357 mL | 0.2714 mL | 0.5429 mL | 0.6786 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 20-甲氧基人参皂苷Rg3; 20-Methoxyginsenoside Rg3 | CFN95763 | N/A | C43H74O13 = 799.1 | 10mg | QQ客服:1413575084 |
| L-苯丙氨酸; L-Phenylalanine | CFN93152 | 63-91-2 | C9H11NO2 = 165.19 | 20mg | QQ客服:2159513211 |
| 反式-1,2二苯乙烯; trans-Stilbene | CFN70005 | 103-30-0 | C14H12 = 180.2 | 20mg | QQ客服:1457312923 |
| 葡萄糖庭荠素; Glucoalyssin | CFN00499 | 499-37-6 | C13H24KNO10S3 = 489.6 | 5mg | QQ客服:1457312923 |